Skip to main content

Table 4 Mean percentage of gaps and maximal gap length

From: Does a tailored intervention to promote adherence in patients with chronic lung disease affect exacerbations? A randomized controlled trial

Variable

Intervention

Control

P value

Mean (SD) gaps for puff inhalers [%]

3.2 (4.7)a

11.7 (18.6)c

.008

Mean (SD) gaps for inhalation with dry powder capsules [%]

4.6 (4.4)b

9.8 (8.9)d

.009

Mean (SD) maximal gap length for puff inhalers [days]

1.6 (2.0)a

11.6 (25.6)c

.025

Mean (SD) maximal gap length for dry powder capsules [days]

2.6 (2.7)b

5.9 (5.2)d

.002

  1. an = 57; bn = 41; cn = 60; dn = 49